Trump mulls fast-tracking AstraZeneca vaccine development before US elections

Trump ministration was mulling to fast-track an experimental COVID-19 vaccine ahe of vember elections, an American media outlet reported on August 24. vaccine, which is jointly developed by AstraZeneca and Oxford University has previously shown “good signs”. With Trump claiming to make COVID-19 vaccine available for American use before end of this year, focus has shifted on w shifted on this candidate. 

AstraZeneca denies posibilities 

As per international media reports, one option that was being explored was  Food and Drug ministration (FDA) awarding "emergency use authorization" in October to potential vaccine. AstraZeneca, on or hand,  has denied any such possibilities. "AstraZeneca has t discussed emergency use authorization with US government and it would be premature to speculate on that possibility," a spokeswoman for AstraZeneca said in a statement.

This comes AstraZeneca said that its COVID-19 vaccine is showing 'good data' and is alrey in process of large scale human trials. lab sees its COVID-19 vaccine as a front runner in race against vel coronavirus. As per reports, AstraZeneca is one of  UK's most valuable listed companies and anunced astounding second-quarter results that beat its sales and profit estimates. Pascal Soriot, AstraZeneca Chief Executive, is reported to have said that development of vaccine was progressing well. He ded that re has been good news so far and it needs to show efficacy in clinical programme.

Re: Argentina, Mexico To Produce AstraZeneca Coronavirus Vaccine For Latin America

Re: UK Pharma Giant AstraZeneca Optimistic About Its COVID-19 Vaccine, Says 'Good Data So Far'

As per reports, AstraZeneca alrey has deals in place with countries to make more than two billion doses of its COVID-19 vaccine, which is being developed in collaboration with University of Oxford.  company also said that its COVID-19 vaccine could be approved by end of this year. According to international media reports, company has been busy working on vaccine and has received huge funds from government, signed several supply deals, and was even subject of a mega-merger speculation. 

Re: Emergent Inks $174 Million Deal With AstraZeneca To Produce COVID-19 Vaccine Candidate

Re:  UK Pharma Giant AstraZeneca Optimistic About Its COVID-19 Vaccine, Says 'Good Data So Far'